Last reviewed · How we verify

NCT07139808

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

Recruiting now NA Last updated 7 April 2026
What this trial tests

NA trial testing GK5 CGKM in Type1diabetes in 12 participants. Currently enrolling.

Timeline
1 August 2025
Primary endpoint
1 October 2026
1 December 2026

Quick facts

Lead sponsorHenan University of Science and Technology
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment12
Start date1 August 2025
Primary completion1 October 2026
Estimated completion1 December 2026
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Henan University of Science and Technology

Who can join

18 and older, any sex, with Type1diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is to evaluate the accuracy and safety of a novel real-time continuous glucose and ketone monitoring system among adult patients with type 1 diabetes mellitus (T1DM) with respect to Yellow Spring Instrument (YSI) and Randox reference venous plasma sample measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

Other Henan University of Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07139808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing